BMI, health conditions and medical history decide GLP-1 weight-loss eligibility
Summary
GLP-1 weight-loss drug eligibility depends on BMI, specific health conditions and medical history, and these 14 points show who FDA labels for Wegovy, Zepbound and Saxenda include and exclude
Description from Quartz.
Who is covering this
- GLP-1 weight-loss drugs can cause blindness in rare cases, FDA warns
-
BMI, health conditions and medical history decide GLP-1 weight-loss eligibility
GLP-1 weight-loss drug eligibility depends on BMI, specific health conditions and medical history, and these 14 points show who FDA labels for Wegovy, Zepbound and Saxenda include and exclude
Related stories
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
29 sourcesvia BBC NewsTruth score 9111
Actor Ajay Devgn moves High Court against FDA notice over Vimal Elaichi ads
7 sourcesvia The HinduTruth score 731
Blood pressure medication recalled nationwide
4 sourcesvia USA TODAYTruth score 671
Patanjali ghee among Rs 9 crore food stock seized in Maharashtra FDA crackdown
3 sourcesvia India TodayTruth score 54
Senate committee sets key vote for Trump FDA nominee
5 sourcesvia The HillTruth score 71
Urgent recall of coffee and vanilla ice cream sold at Lidl upgraded to highest risk level over contamination with listeria
3 sourcesvia Daily MailTruth score 53
Comments
Comments need JavaScript.